Skip to main content
OpenTrials

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,486 public trials 1,473 recruiting studies
Refine in advanced search Browse all conditions

Colonic Diseases trial results

Active, Not Recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

NCT03785249

Conditions
Advanced Cancer, Colonic Diseases, Colonic Neoplasms, +20 more
Locations
  • Local Institution - 001-826 Birmingham, Alabama, United States
  • Local Institution - 001-965 Anchorage, Alaska, United States
  • Local Institution - 001-821 Phoenix, Arizona, United States
  • Local Institution - 001-873-A Tucson, Arizona, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease

NCT04595266

Conditions
Colonic Diseases, Colorectal Cancer Metastatic, Colorectal Neoplasms, +10 more
Locations
  • Hospital Clínic Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • H. Univ. Ramón y Cajal Madrid, Spain
View Trial Details
Active, Not Recruiting

A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

NCT04606472

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +43 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

NCT05485974

Conditions
Bronchial Neoplasms, Cancer, Cancer of Pancreas, +28 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas, California, United States
  • The Oncology Institute of Hope and Innovation Glendale, California, United States
  • The Oncology Institute of Hope and Innovation Long Beach, California, United States
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

NCT05163028

Conditions
Bronchial Neoplasms, Cancer, Cancer of Colon, +28 more
Locations
  • City of Hope Duarte, California, United States
  • California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • California Cancer Associates for Research and Excellence, Inc. (cCare) San Marcos, California, United States
View Trial Details

Related conditions